WCC Biomedical

Private

TaiwanHealthcare & Life Scienceshttps://wccbiomedical.com/

Last Round

Series C

Sep 1, 2024

Total Funding Raised

$23.09M

Company Overview

WCC Biomedical is a biotechnology company that specializes in the development and manufacturing of microarray patches (MAPs) for pharmaceutical, vaccine, and cosmetic applications using its proprietary WINMAP technology.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Fashion & Beauty, D2C Brands

Business Model

B2B

Customer Profile

Services & Consulting, Hardware Sales, Data as a Service

AI Layer

Non-AI

Keywords

microarray patchMAPmicroneedle patchCDMOtransdermal deliveryneedle-free injectiondrug delivery systembiotech manufacturingmRNA deliverycosmetic patchODMpainless vaccineskincare tech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

WCC Biomedical Comps

Public and private peers based on sector, stage, and business model.

WCC Biomedical comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

WCC Biomedical Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Series C	Sep 1, 2024
Series B	Jun 14, 2023
Series A	Feb 1, 2022
Grant	Jun 1, 2019

View all Funding Rounds

Key People

Founding team and executive leadership

TJ Liu

Chairman and CEO

Executive Team

WCC Biomedical Investors

Notable investors and investment history

WCC Biomedical investors
Investor	Rounds
National Science and Technology Council	Grant
CTBC Venture Capital	Series B
Taiwan Cooperative Venture Capital	Series B

View all Investors

WCC Biomedical Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

WCC Biomedical Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about WCC Biomedical's valuation, stock price, and market status.

Firmographic Details

HeadquartersTaiwan

Employee Range22

Year Founded2014

Last FundingSep 1, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.